Literatur
Temme S et al (2022) 19F-MRT basierte Visualisierung von entzündlichen Prozessen im Gefäßsystem. Gefässchirurgie. https://doi.org/10.1007/s00772-022-00947-5
Baxter GM, McKechnie S, Duffy P (1990) Colour Doppler ultrasound in deep venous thrombosis: a comparison with venography. Clin Radiol 42:32–36
Thomas SM, Goodacre SW, Sampson FC, van Beek EJR (2008) Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol 63:299–304
Sampson FC, Goodacre SW, Thomas SM, van Beek EJR (2007) The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 17:175–181
Temme S, Grapentin C, Güden-Silber T, Flögel U (2016) Active targeting of perfluorocarbon nanoemulsions. In: Fluorine magnetic resonance imaging. CRC Press, S 97–133
Sirol M et al (2005) Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis 182:79–85
Sirol M et al (2005) Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 112:1594–1600
Spuentrup E et al (2008) MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 18:1995–2005
von zur Muhlen C et al (2008) Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 118:258–267
Tung C‑H et al (2003) Novel factor XIII probes for blood coagulation imaging. Chembiochem 4:897–899
Owens D III, Peppas N (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
Mohamed M et al (2019) PEGylated liposomes: immunological responses. Sci Technol Adv Mater 20:710–724
Temme S et al (2015) Noninvasive imaging of early venous thrombosis by 19F magnetic resonance imaging with targeted perfluorocarbon nanoemulsions. Circulation 131(16):1405–1414
Krämer W et al (2019) Rational manufacturing of functionalized, long-term stable perfluorocarbon-nanoemulsions for site-specific 19F magnetic resonance imaging. Eur J Pharm Biopharm 142:114–122
Straub T et al (2020) MRI-based molecular imaging of epicardium-derived stromal cells (EpiSC) by peptide-mediated active targeting. Sci Rep 10:21669
Grapentin C et al (2014) Optimization of perfluorocarbon nanoemulsions for molecular imaging by 19F MRI. In: Nanomedicine. One Central Press, S 268–286
Wang X et al (2020) Fluorine-19 magnetic resonance imaging of activated platelets. J Am Heart Assoc 9:e16971
Jaffer FA et al (2004) Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110:170–176
Westrick RJ, Winn ME, Eitzman DT (2007) Murine models of vascular thrombosis. Arterioscler Thromb Vasc Biol 27:2079–2093
Lanza GM et al (2019) An unmet clinical need: the history of thrombus imaging. J Nucl Cardiol 26:986–997
Schwarz M et al (2004) Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries. Faseb J 18:1704–1706
Schwarz M et al (2006) Conformation-specific blockade of the Integrin GPIIb/IIIa. Circ Res 99:25–33
Wang X et al (2012) Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of Thrombolysis in mice. Circulation 125:3117–3126
Flögel U et al (2021) Multi-targeted 1H/19F MRI unmasks specific danger patterns for emerging cardiovascular disorders. Nat Commun 12:5847
Danksagung
Diese Arbeit wurde durch die Sonderforschungsbereiche (SFB 1116: B10 für UF und MG; TRR 259: B08 für MG und B03 für UF) und die Einzelanträge (ST 1209/1‑2, FL 303/6‑2, GR 4374/2-2) der Deutschen Forschungsgemeinschaft sowie Förderprogramme der Europäischen Union (MSCA-ITN-2019, NOVA-MRI; MSCA-RISE-2019, PRISAR2 für UF) unterstützt.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Temme, P. Kleimann, M. Grandoch, X. Wang, K. Peter, F. Simon, J. Schrader und U. Flögel geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Temme, S., Kleimann, P., Grandoch, M. et al. Aktives Targeting zur Visualisierung von thrombotischen Prozessen mittels 19F-MRT. Gefässchirurgie 28, 52–57 (2023). https://doi.org/10.1007/s00772-022-00961-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-022-00961-7